Company / SG&A Expense
Warby Parker Inc. SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$475.9M
FY2025
5-year range
$224.8M / $475.9M
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#69 of 158
Health Care
What the data says
At $476M, Warby Parker Inc.'s sg&a expense ranks #90 of 158 in the Health Care sector. SG&A Expense has increased for 4 consecutive years, from $225M in FY2021 to $476M in FY2025.
Based on SEC 10-K filings.
$476M in FY2025 with a 5-year CAGR of +10.6%.
Increased from $437M to $476M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +18.3%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
#90 of 158 in Health CareTop 56% of 158This company $475.9M Sector average $175.9B
▼
-99.7% below sector average
Key checks
Key Insights
- Warby Parker Inc.'s sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +10.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 4.2% year-over-year.
- Ranks #69 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $475.9M | +4.2% |
| FY2024 | $456.9M | +4.5% |
| FY2023 | $437.2M | +52.0% |
| FY2022 | $287.6M | +27.9% |
| FY2021 | $224.8M | -21.8% |
| FY2020 | $287.6M | +27.9% |
| FY2019 | $224.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026